SOLIDARITY trials
COVID-19 treatment: SOLIDARITY trial is restarting with 3 drugs this time
The drug candidates for repurposing are imatinib, a cancer drug; infliximab, an antibody; and artesunate, an anti-malarial drug. The tests seek to explore possible drugs that can be repurposed to treat severely affected COVID-19 patients
WHO mega trial results out: Remdesivir, Interferon fail to prove effective
None of the four drug/drug combinations that were deployed in the WHO’s SOLIDARITY trial were found to be effective in reducing mortality, not even the much-hyped anti-viral drug Remdesivir
- Risks of infectious diseases, malnutrition soar as Israel resumes attacks on Gaza Strip
- Greek health workers intensify protests for pay hike, more staff
- Censorship of pro-Palestine content on social media continues
- On day of historic strike in São Paulo, thousands rally against privatization
- Nearly the entire US House of Representatives just equated anti-Zionist to anti-semitism
